Active	Status	Sponsor type	Region	Phase	Filter
7 Active 4 Inactive 11 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Xu, Ling
NCT05148195: A Phase II Study of Envofolimab and BD0801 With/Without Chemotherapy in Patients With Advanced Solid Tumors	Terminated	2	86	RoW	Envofolimab, BD0801, Docetaxel, Irinotecan, Leucovorin calcium, 5-Fluorouridine	Jiangsu Simcere Pharmaceutical Co., Ltd.	Advanced Solid Tumor	07/23	07/23
Zhu, Wenwei
TQB3454-Ib-01, NCT06218771: A Study of TQB3454 Tablets in Patients With Blood Tumors	Recruiting	1/2	80	RoW	TQB3454 Tablets	Chia Tai Tianqing Pharmaceutical Group Co., Ltd.	Acute Myeloid Leukemia, Myelodysplastic Syndromes	06/25	12/25
Fang, Shengquan
NCT06696261: A Study of Lianxiaxiaopi Granules in the Treatment of Postprandial Distress Syndrome	Not yet recruiting	3	342	RoW	Lianxiaxiaopi Granules, a simulated agent of Lianxiaxiaopi Granules	Tasly Pharmaceutical Group Co., Ltd	Postprandial Distress Syndrome	06/26	08/26